Nektar Therapeutics

NKTR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
NKTR Income Statement
NKTR Balance Sheet
NKTR Cash Flow
Congress Trading

Recent trades of NKTR by members of U.S. Congress

Politician Type Traded
Josh Gottheimer House / D Sale $1,001 - $15,000 Jun. 21, 2018
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jun. 06, 2018
NKTR Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
NKTR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NKTR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NKTR's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $50,000 Jan 20, 2022 Issue: Health Issues
  • $50,000 Oct 20, 2021 Issue: Health Issues
  • $50,000 Jul 20, 2021 Issue: Health Issues
  • $50,000 Apr 20, 2021 Issue: Health Issues
  • $50,000 Jan 21, 2021 Issue: Health Issues
  • $50,000 Oct 20, 2020 Issue: Health Issues
  • $60,000 Jul 20, 2020 Issue: Health Issues
  • $14,000 Jul 20, 2020 Issue: Pharmacy
  • $60,000 Apr 26, 2020 Issue: Health Issues
  • $60,000 Feb 25, 2020 Issue: Health Issues
  • $50,000 Jan 21, 2020 Issue: Health Issues
  • $14,000 Jan 15, 2020 Issue: Pharmacy
  • $20,000 Jan 10, 2020 Issue: Pharmacy
  • $20,000 Oct 16, 2019 Issue: Pharmacy
  • $50,000 Oct 08, 2019 Issue: Health Issues
  • $50,000 Jul 18, 2019 Issue: Health Issues
  • $20,000 Jul 15, 2019 Issue: Pharmacy
  • $50,000 Apr 12, 2019 Issue: Health Issues
  • $20,000 Apr 11, 2019 Issue: Pharmacy
  • $50,000 Jan 20, 2019 Issue: Health Issues
  • $20,000 Jan 18, 2019 Issue: Pharmacy
  • $20,000 Oct 18, 2018 Issue: Pharmacy
  • $50,000 Oct 16, 2018 Issue: Health Issues
  • $108,000 Oct 16, 2018 Issue: Pharmacy
  • $20,000 Jul 20, 2018 Issue: Taxation/Internal Revenue Code Pharmacy
  • $50,000 Jul 20, 2018 Issue: Health Issues
  • $21,600 Jul 18, 2018 Issue: Pharmacy
  • $20,000 Apr 20, 2018 Issue: Taxation/Internal Revenue Code Pharmacy
  • $60,000 Apr 18, 2018 Issue: Health Issues
  • $72,000 Apr 17, 2018 Issue: Pharmacy
  • $20,000 Jan 22, 2018 Issue: Taxation/Internal Revenue Code Pharmacy
  • $144,000 Jan 19, 2018 Issue: Pharmacy
  • $30,000 Jan 18, 2018 Issue: Health Issues
  • $20,000 Oct 20, 2017 Issue: Taxation/Internal Revenue Code Pharmacy
  • $20,000 Oct 20, 2017 Issue: Pharmacy
  • $30,000 Oct 13, 2017 Issue: Health Issues
  • $20,000 Apr 20, 2017 Issue: Pharmacy
  • $60,000 Apr 01, 2017 Issue: Pharmacy
  • $20,000 Jan 23, 2017 Issue: Pharmacy
  • $60,000 Jan 19, 2017 Issue: Pharmacy
  • $20,000 Oct 20, 2016 Issue: Pharmacy
  • $60,000 Oct 20, 2016 Issue: Pharmacy
  • $20,000 Jul 20, 2016 Issue: Pharmacy
  • $60,000 Jul 20, 2016 Issue: Pharmacy
  • $20,000 Apr 20, 2016 Issue: Pharmacy
  • $60,000 Apr 20, 2016 Issue: Pharmacy
  • $10,000 Jan 20, 2016 Issue: Pharmacy
  • $90,000 Jan 20, 2016 Issue: Pharmacy
  • $90,000 Oct 20, 2015 Issue: Pharmacy
  • $90,000 Jul 20, 2015 Issue: Pharmacy
  • $90,000 Apr 20, 2015 Issue: Pharmacy
  • $100,000 Jan 20, 2015 Issue: Pharmacy
  • $90,000 Oct 20, 2014 Issue: Pharmacy
  • $90,000 Jul 21, 2014 Issue: Pharmacy
  • $10,000 Oct 01, 2008 Issue: Health Issues
  • $10,000 Jul 18, 2008 Issue: Health Issues
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Immunotherapeutic tumor treatment method Aug. 06, 2024
  • Patent Title: Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods Jul. 16, 2024
  • Patent Title: Immunotherapeutic tumor treatment method Jul. 09, 2024
  • Patent Title: Methods of preparing a monodisperse oligo(ethylene glycol) reagent composition Jun. 25, 2024
  • Patent Title: Method of making releasable polymeric reagents Mar. 19, 2024
  • Patent Title: Alkoxylation methods Dec. 05, 2023
  • Patent Title: Multi-arm polymeric prodrug conjugates of taxane-based compounds Nov. 14, 2023
  • Patent Title: Multi-arm polymer conjugates of tlr agonist compounds and related immunotherapeutic treatment methods Sep. 05, 2023
  • Patent Title: Multi-arm polymeric alkanoate conjugates Jun. 13, 2023
  • Patent Title: Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method Apr. 25, 2023
  • Patent Title: Conjugates of a factor viii moiety having an oxime-containing linkage Apr. 18, 2023
  • Patent Title: Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds Mar. 28, 2023
  • Patent Title: Oligomer-corticosteroid conjugates Oct. 11, 2022
  • Patent Title: Polymer derivatives having particular atom arrangements Sep. 20, 2022
  • Patent Title: Polymer-sunitinib conjugates Aug. 23, 2022
  • Patent Title: Polymer-des-ethyl sunitinib conjugates Aug. 09, 2022
  • Patent Title: Immunotherapeutic treatment method using an interleukin-2 receptor beta-selective agonist in combination with adoptive cell transfer therapy May. 03, 2022
  • Patent Title: Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates Mar. 08, 2022
  • Patent Title: N-methyl-n-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the κ opioid receptor Feb. 08, 2022
  • Patent Title: Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method Jan. 11, 2022
  • Patent Title: Method of making a water-soluble polymer-factor viii moiety conjugate Oct. 12, 2021
  • Patent Title: Chemically modified small molecules Sep. 28, 2021
  • Patent Title: Method of preparing carboxylic acid functionalized polymers Sep. 07, 2021
  • Patent Title: Kappa opioid agonists and uses thereof Sep. 07, 2021
  • Patent Title: Method of refolding an interleukin-2 (il-2) protein Aug. 17, 2021
  • Patent Title: Methods of treating cyp2d6 alternative metabolizers Jun. 15, 2021
  • Patent Title: Polymer-semaxanib moiety conjugates May. 18, 2021
  • Patent Title: Conjugates of an il-2 moiety and a polymer Mar. 30, 2021
  • Patent Title: Particulate materials Mar. 16, 2021
  • Patent Title: Methods for preparing functionalized polymers from polymer alcohols Mar. 09, 2021
  • Patent Title: Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds Jan. 19, 2021
  • Patent Title: Oligomer-beta blocker conjugates Jan. 05, 2021
  • Patent Title: Oligomer-phenothiazine conjugates Dec. 22, 2020
  • Patent Title: Opioid agonists and uses thereof Dec. 15, 2020
  • Patent Title: Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine Nov. 24, 2020
  • Patent Title: Protease inhibitors having enhanced features Oct. 20, 2020
  • Patent Title: Compositions of particulate coformulation Oct. 13, 2020
  • Patent Title: Il-2rβ-selective agonists in combination with an anti-ctla-4 antibody or an anti-pd-1 antibody Sep. 29, 2020
  • Patent Title: N-maleimidyl polymer derivatives Sep. 15, 2020
  • Patent Title: Morphinan derivatives for the treatment of neuropathic pain Sep. 08, 2020
  • Patent Title: Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method Sep. 01, 2020
  • Patent Title: Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds Aug. 11, 2020
  • Patent Title: Composition comprising a polymeric reagent Jun. 30, 2020
  • Patent Title: Polymer-sunitinib conjugates Jun. 16, 2020
  • Patent Title: Combination-based treatment method May. 19, 2020
  • Patent Title: Polymer derivatives having particular atom arrangements May. 12, 2020
  • Patent Title: Compositions and methods for achieving sustained therapeutic drug concentrations in a subject Jan. 07, 2020
  • Patent Title: Oligomer-phenothiazine conjugates Nov. 26, 2019
  • Patent Title: Polymer-semaxanib moiety conjugates Nov. 05, 2019
  • Patent Title: Multi-arm polymer prodrugs Nov. 05, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of NKTR in WallStreetBets Daily Discussion

NKTR News

Recent insights relating to NKTR

CNBC Recommendations

Recent picks made for NKTR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NKTR

NKTR Top Shareholders
Shareholder
Shares Held
NKTR Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NKTR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NKTR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top